Merosin and congenital muscular dystrophy

Microscopy Research and Technique

Volumn 48, Issue 3-4, 2000, Pages 181-191

  Miyagoe Suzuki, Yuko ^a   Nakagawa, Masahiro ^a   Takeda, Shin'ichi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Basement membrane; Brain white matter; Congenital muscular dystrophy; Laminin 2 chain; Peripheral nerve; Skeletal muscle

Indexed keywords

CHAINS; GENES; MAGNETIC RESONANCE IMAGING; MAMMALS; MUSCLE;

BASEMENT MEMBRANE; BRAIN WHITE MATTER; CONGENITAL MUSCULAR DYSTROPHY; ISOFORMS; LAMININ; LAMININ Α2 CHAIN; MUSCULAR DYSTROPHY; PERIPHERAL NERVES; SKELETAL MUSCLE; WHITE MATTER;

BRAIN;

MEROSIN;

ARTICLE; CEREBELLUM HYPOPLASIA; GENE DISRUPTION; GENE MUTATION; GENE TARGETING; MOUSE; MUSCLE ATROPHY; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL;

EID: 0033961055     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q     Document Type: Article

References (124)

1. Allamand V, Sunada Y, Salih MAM, Straub V, Ozo CO, Al-Turaili MHS, Akbar M, Kolo T, Colognato H, Zhang. X, Sorokin LM, Yurchenco PD, Tryggvason K, Campbell KP. 1997. Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2-chain. Hum Mol Genet 6:747-752.
2. Andre F, Filippi P, Feracci H. 1994. Merosin is synthesized by thyroid cells in primary culture irrespective of cellular organization. J Cell Sci 107:183-193.
3. Anton ES, Sandrock A, Mathew WD. 1994. Merosin promotes neurite growth and Schwann cell migration in vitro and nerve regeneration in vivo: evidence using an antibody to merosin ARM-1. Dev Biol 164:133-146.
4. Arahata K, Hayashi YK, Koga R, Goto K, Lee JH, Miyagoe Y, Ishii H, Tsukahara T, Takeda S, Woo M, Nonaka I, Matsuzaki T, Sugita H. 1993. Laminin in animal models for muscular dystrophy. Proc Jpn Acad 69:259-264.
5. Aumailley M, Smyth N 1998. The role of laminins in basement membrane function. J Anat 193:1-21.
6. Beaulieu JF, Vachon PH. 1994. Reciprocal expression of laminin A-chain isoforms along the crypt-villus axis in the human small intestine. Gastroenterology 106:829-839.
7. Belkin AM, Zhidkova NI, Balzac F, Altruda F, Tomatis D, Maier A, Tarone G, Koteliansky VE, Burridge K. 1996. Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells. J Cell Biol 132:211-226.
8. Bernier SM, Utani A, Sugiyama S, Doi T, Polistina C, Yamada Y. 1994. Cloning and expression of laminin α2 chain (M-chain) in the mouse. Matrix Biol 14:447-455.
9. Bradley WG, Jaros E. 1979. Involvement of peripheral and central nerves in murine dystrophy. Ann NY Acad Sci 317:132-142.
10. Bradley WG, Jenkison M. 1973. Abnormalitis of peripheral nerves in murine muscular dystrophy. J Neurol Sci 18:227-247.
11. Brandenberger R, Chiquet M. 1995. Distinct heparin-binding and neurite-promoting properties of laminin isoforms isolated from chick heart. J Cell Sci 108:3099-3108.
12. Bunge MB, Bunge RP. 1986. Likage between Schwann cell extracellular matrix production and ensheathment function. Ann NY Acad Sci 486:241-247.
13. Bunge MB, Williams AK, Wood PM. 1982. Neuron-Schwann cell interaction in basal lamina function. Dev Biol 92:449-460.
14. Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, Martin GR, Meneguzzi G, Paulsson M, Sanes J, Timpl R, Tryggvason K, Yamada Y, Yurchenco PD. 1994. A new nomenclature for the laminins. Matrix Biol 14:209-211.
15. Byers TJ, Lidov HGW, Kunkel LM. 1993. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 4:77-81.
16. Calof AL, Lander AD. 1991. Relationship between neuronal migration and cell-substratum adhesion: laminin and merosin promote olfactory neuronal migration but are anti-adhesive. J Cell Biol 115:779-794.
17. Campbell KP. 1995. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80:675-679.
18. Chang AC, Wadsworth S, Coligan JE. 1993. Expression of merosin in the thymus and its interaction with thymocytes. J. Immunol, 151:1789-1801.
19. Cohen J, Johnson AR. 1991. Differential effects of laminin and merosin on neurite outgrowth by developing retinal ganglion cells. J Cell Sci Suppl 15:1-17.
20. Cohn RD, Herrmann R, Sorokin L, Wewer UM, Voit T. 1998. Laminin α2 chain deficient congenital muscular dystrophy. Variable epitope expression in severe and mild cases. Neurology, 51:94-100.
21. Colognato H, Winkelman DA, Yuchenco PD. 1999. Laminin polymerization induces a Receptor-Cytoskeleton Network. J Cell Biol 145:619-631.
22. Dobyns WB, Pagon RA, Armstrong D, Curry CJ, Greenberg F, Grix A, Holmes LB, Laxova R, Michels VV, Robinow M, Zimmerman RL. 1989. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 32:195-210.
23. Douville PJ, Harvey WJ, Carbonetto S 1988. Isolation and partial characterization of high affinity laminin receptors in neural cells. J Biol Chem 263:14964-14969.
24. Echtermeyer F, Schober S, Poschl E, von der Mark H, von der Mark K. 1996. Specific induction of cell motility on laminin by alpha 7 integrin. J Biol Chem 271:2071-2075.
25. Ehrig K, Leivo I, Argraves WS, Ruoslahti E, Engvall E. 1990. Merosin, a tissue specific basement membrane protein is a laminin-like protein. Proc Natl Acad Sci USA 87:3264-3268.
26. Einheber S, Milner TA, Giancotti F, Salzer JL. 1993. Axonal regeneration of Schwann cell integrin expression suggests a role for a6β4 in myelination. J Cell Biol 123:1223-1236
27. Eldridge CF, Bunge MB, Bunge RP. 1989. Differentiation of axon-related Schwann cells in vitro: II. Control of myelin formation by basal lamina. J Neurosci 9:625-638.
28. Engvall E, Earwicker D, Day A, Muir D, Manthope M, Paulsson M. 1992. Merosin promotes cell attachment and neurite outgrowth and is a component of the neurite-promoting factor of RN22 Schwannoma cells. Exp Cell Res 198:115-123.
29. Ervasti JM, Campbell KP. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122:809-823.
30. Feltri ML, Scherer SS, Nemni R, Kamholz J, Vogelbacker H, Scott MO, Canal N, Quaranta V, Wrabetz L. 1994. β4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent. Development 120:1287-1301.
31. Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, Carbonetto S. 1993. Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem 268:14972-14980.
32. George-Weinstein M, Foster RF, Gerhart JV, Kaufman SJ. 1993. In vitro and in vivo expression of alpha 7 integrin and desmin define the primary and secondary myogenic lineages. Dev Biol 156:209-229.
33. Guicheney P, Vignier N, Helbling-Leclerc A, Nissinen M, Zhang X, Cruaud C, Lambert JC, Richelme C, Topaloglu H, Merlini L, Barois A, Schwartz K, Tome FM, Tryggvason K, Fardeau M. 1997. Genetics oflaminin alpha 2 chain (or merosin) deficient congenital muscular dystrophy: from identification of mutations to prenatal diagnosis. Neuromusc Disord 7:180-186.
34. Guicheney P, Vigner N, Zhang X, He Y, Cruaud C, Frey V, Helbling-Leclerc A, Richard P, Estournet B, Merlini L, Topaloglu H, Mora M, Harpey JP Haenggeli CA, Barois A, Hainque B, Schwartz K, Tome FM.S, Fardeau M, Tryggvason K. 1998. PCR based mutation screening of the laminin α2 chain gene (LAMA2): application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy. J Med Genet 34:211-217.
35. Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL, McNally EM. 1998. Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 142:1279-1287.
36. Hagg T, Portera-Cailliau C, Jucker M, Engvall E. 1997. Laminins of the adult mammalian CNS; laminin α2 (merosin M-) chain immunoreactivityis associated with neuronal processes. Brain Res 764: 17-27.
37. Haltia M, Leivo I, Somer H, Pihko H, Paetau A, Kivela T, Tarkkanen A, Tome F, Engvall E, Santavuori P. 1997. Muscle-eye-brain disease: a neuropathological study. Ann Neurol 41:173-180.
38. Hayashi YK, Engvall E, Arikawa-Hirasawa E, Goto K, Koga R, Nonaka I, Sugita H, Arahata K 1993. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci 119:53-64.
39. Hayashi YK, Ishihara T, Domen K, Hori H, Arahata K. 1997. A benign allelic form of laminin α2 chain deficient muscular dystrophy. Lancet 349:1147.
40. Hayashi YK, Chou FL, Engvall E, Ogawa M, Matsuda C, Hirabayashi S, Yokochi K, Ziober BL, Kramer RH, Kaufman SJ, Ozawa E, Goto Y, Nonaka, I, Tsukahara T, Wang JZ, Hoffman EP, Arahata K. 1998. Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet 19:94-97.
41. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tome FM, Schwartz K, Fardeau M, Tryggvason K, Guicheney P 1995. Mutation in the laminin α2-chain gene (LAMA2. cause merosin-deficient congenital muscular dystrophy. Nat Genet 11:216-218.
42. Henry MD, Campbell KP. 1998. A role for dystroglycan in basement membrane assembly. Cell 95:859-870.
43. Hillaire D, Leclerc A, Faure S, Topaloglu H, Chiannilkulchai N, Guicheney P, Grinas L, Legos P, Philpot J, Evangelista TRouton M-C, Mayer M, Pellissier J-F, Estournet B, Barois A, Hentati F, Feingold N, Beckmann JS, Dubowitz V, Tome FMS, Fardeau M. 1994. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 3:1657-1661.
44. Hodges BL, Hayashi YK, Nonaka I, Wang W, Arahata K, Kaufman SJ. 1997. Altered expression of the alpha7betal integrin in human and murine muscular dystrophies. J Cell Sci 110:2873-2881.
45. Huizar P, Kuno M, Miyata Y. 1975. Electrophysiological properties of spinal motoneurones of normal and dystrophic mice. J Physol 248:231-246.
46. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702.
47. Ishii H, Hayashi YK, Nonaka I, Arahata K. 1997. Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy. Neuromusc Disord 7:191-197.
48. Jaros E, Jenkinson M. 1983. Quantitative studies of the abnormal axon-Schwann cell relationship in the peripheral motor and sensory nerves of the dystrophic mouse. Brain Res 258:181-196.
49. Jucker M, Tian M, Norton DD, Sherman C, Kusiak JW. 1996. Laminin alpha 2 is a component of brain capillary basement membrane: reduced expression in dystrophic dy mice. Neuroscience 71:1153-1161.
50. Kivirikko S, McGrath JA, Aberdam D, Ciatti S, Baudoin C, Dunnill MG.S, McMillan JR, Eady RA.J, Ortonne JR Meneguzzi G, Uitto J, Christiane AM. 1995. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3. in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet 4:959-962.
51. Kobayashi O, Hayashi Y, Arahata K, Ozawa E, Nonaka I. 1996. Congenital muscular dystrophy: clinical and pathologic study of 50 patients with the classical (Occidental) merosin-positive form. Neurology 46:815-818.
52. Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, Segawa M, Yoshioka M, Saito K, Osawa M, Hamano K, Sakakihara Y, Nonaka I, Nakagome Y, Kanazawa I, Nakamura Y, Tokunaga K, Toda T. 1998. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394: 388-392.
53. Kuang W, Xu H, Vachon PH, Engvall E. 1998a. Disruption of the lama2 gene in embryonic stem cells: laminin alpha 2 is necessary for sustenance of mature muscle cells. Exp Cell Res 241:117-125.
54. Kuang W, Xu H, Vachon PH., Liu L, Loechel F, Wewer U.M, Engvall E. 1998b. Merosin-deficient congenital muscular dystrophy: Partial genetic correction in two mouse models. J Clin Invest 102:844-852.
55. Lamer S, Carlier RY, Pinard JM, Mompoint D, Bagard C, Burdairon E, Estournet B, Barois A, Vallee C. 1998. Congenital muscular dystrophy: use of brain MR imaging findings to predict merosin deficiency. Radiology 206:811-816.
56. Leivo I, Engvall E. 1988. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle develpoment. Proc Natl Acad Sci USA 85:1544-1548.
57. Leyten QH, Gabreels FJ, Renier WO, van Engelen BG, ter Laak HJ, Sengers RC, Thijssen HO. 1995. White matter abnormalities in congenital muscular dystrophy. J Neurol Sci 129:162-169.
58. MacPike AD, Meier H. 1976. Comparison of dy and dy2J, two alleles expressing forms of muscular dystrophy in the mouse. Proc Soc Exp Biol Med 151:670-672.
59. Madrid RE, Jaros E, Cullen MJ, Bradly WG. 1975. Genetically determined defect of Schwann cell besement membrane in dystrophic mouse. Nature 257:319-321.
60. Martin PT, Kaufman SJ, Kramer RH, Sanes JR. 1996. Synaptic integrins in developing, adult, and mutant muscle: selective association of alphal, alpha7A, and alphaTB integrins with the neuromuscular junction. Dev Biol 174:125-139.
61. Matsumura K, Yamada H, Saito. F, Sunada. Y, Shimizu T. 1997. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromusc Disord 7:7-12.
62. Mayer U, Saher G, Fassler R, Bornemann A, Echtermeyer F, von der Mark H, Miosge N, Poschl E, von der Mark K. 1997. Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nat Genet 17:318-323.
63. Meier H, Southard JL. 1970. Muscular dystrophy in the mouse caused by an allele at the dy-locus. Life Sci 9:137-142.
64. Mercuri E, Muntoni F, Berardinelli A, Pennock J, Sewry C, Philpot J, Dubowitz V. 1995. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status. Neuropaediatrics 26:3-7.
65. Michelson AM, Russell E, Harman P. 1995. Dystrophia Muscularis: a hereditary primary myopathy in the house mouse. Proc Natl Acad Sci USA 41:1079-1084.
66. Minetti C, Bado M, Morreale G, Pedemonte M, Cordone G. 1996. Disruption of muscle basal lamina in congenital muscular dystrophy with merosin deficiency. Neurology 46:1354-1358.
67. Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima Y, Arahata K, Nabeshima Y, Takeda S. 1997. Laminin α2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin-2)-deficient congenital muscular dystrophy. FEBS Lett 415:33-39.
68. Montanaro F, Lindenbaum M, Carbonetto S. 1999. α-dystroglycan is a laminin receptor involved in extracellular matrix assembly and muscle cell viability. J Cell Biol 145:1325-1340.
69. Mora M, Moroni I, Uziel G, di Blasi C, Barresi R, Farina L, Morandi L. 1996. Mild clinical phenotype in a 12-year-old boy with partial merosin deficiency and central and peripheral nervous system abnormalities. Neuromusc Disord 6:377-381.
70. Naom I, D'Alessandro M, Sewry C, Ferlini A, Topaloglu H, Helbling-Leclerc A, Guicheney P, Schwartz K, Akcoren Z, Dubowitz V, Muntoni F. 1997. The role of immunocytochemistry and linkage analysis in the prenatal diagnosis of merosin-deficient congenital muscular dystrophy. Hum Genet 99:535-540.
71. Nissinen M, Helbling-Leclerc A, Zhang X, Evangelista T, Topaloglu H, Cruaud C, Weissenbach J, Fardeau M, Tome FM, Schwartz K, Tryggvason K, Guicheney P. 1996. Substitution of a conserved cystein-996 in a cystein-rich motif of the laminin α2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet 58:1177-1184.
72. Obremski VJ, Bunge MB. 1995. Addition of purified basal lamina molecules enables Schwann cell ensheathment of sympathetic neurites in culture. Dev Biol 168:124-137.
73. Okada E, Mizuhara V, Nakamura H. 1976. Dysmyelination in the sciatic nerves of dystrophic mice. J Neurol Sci 26:505-520.
74. Osari S, Kobayashi O, Yamashita Y, Matsuishi T, Goto M, Tanabe Y, Migita T, Nonaka I. 1996. Basement membrane abnormality in merosin-negative congenutal musucular dystrophy. Acta Neuropathol 91:332-336.
75. Patton BL, Miner JH, Chiu AY, Sanes JR. 1997. Distribution and function of laminins in the neuromusclar system of developing, adult, and mutant mice. J Cell Biol 139:1507-1521.
76. Pegoraro E, Mancias P, Swerdlow SH, Raikow RB, Garcia C, Marks H, Crawford T, Carver V, Di Cianno B, Hoffman EP. 1996. Congenital muscular dystrophy with primary laminin α2 (merosin) deficiency presenting as inflammatory myopathy. Ann Neurol 40:782-791.
77. Pegoraro E, Marks H, Garcia CA, Crawford T, Mancias P, Connolly AM, Fanin M, Martinello F, Trevisan CP, Angelini C, Stella A, Scavina M, Munk RL, Servidei S, Bonnemann CC, Bertorini T, Acsadi G, Thompson CE, Gagnon D, Hoganson G, Carver V, Zimmerman RA, Hoffman EP. 1998. Laminin α2 muscular dystrophy: genotype/phenotype studies of 22 cases. Neurology 561:101-110.
78. Philpot J, Cowan F, Pennock J, Sewry C, Dubowitz V, Bydder G, Muntoni F. 1999. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromusc Disord 9:81-85.
79. Philpot J, Sewry C, Pennock J, Dubowitz V. 1995. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 5:301-305.
80. Podratz JL, Rodriguez EH, Dinonno ES, Windebank AJ. 1998. Myelination by Schwann cells in the absence of extracellular matrix assembly. Glia 23:383-388.
81. Pulkkinen L, Kimonis V.E, Xu Y, Spanou EN, McLean WH, Uitto J. 1997. Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet 6:669-674.
82. Rasminsky M, Kearney RE, Aguayo AJ, Bray GM. 1978. Conduction of nervous impulses in spinal root and peripheral nerves of dystrophic mice. Brain Res 143:71-85.
83. Richard BL, Nomizu M, Yamada Y, Kleinman HK. 1996. Identification of synthetic peptides derived from laminin α1 and α2 chains with cell type specificity for neurite outgrowth. Exp Cell Res 228:98-105.
84. Richardson L, Kleinman HK, Dym M. 1995. Basement membrane gene expression by Sertoli and peritubular myoid cells in vitro in the rat. Biol Reprod 52:320-330.
85. Ringelmann B, Roder C, Hallmann R, Maley M, Davis M, Grounds M, Sorokin M 1999. Expression of laminin α1, α2, α4, and α5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129 ReJ dy/dy mice. Exp Cell Res 246:165-182.
86. Schittny JC, Yurchenco PD. 1990. Terminal short arm domains of basement membrane laminin are critical for its self-assembly. J Cell Biol 110:825-832.
87. Schuler F, Sorokin LM. 1995. Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J Cell Biol 108:3795-3805.
88. Sewry CA, Philpot J, Sorokin LM, Wilson LA, Naom I, Goodwin F, D'Alessandro M, Dubowitz V, Muntoni F 1996. Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet 347:582-584.
89. Sewry CA, Naom I, D'Alessandro M, Sorokin L, Bruno S, Wilson LA, Dubowitz V, Muntoni F. 1997. Viable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chain. Neuromusc Disord 7:169-175.
90. Sewry CA, Uziyel Y, Torelli S, Buchanan S, Sorokin L, Watt DJ. 1998. Differential labelling of laminin α2 in muscle and neural tissue of dy/dy mice: are there isoforms of the laminin α2 chain? Neuropathol Appl Neurol 24:66-72.
91. Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V. 1995. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol 10:472-475.
92. Smalheiser NR, Schwartz NB. 1987. Cranin, a laminin-binding protein of cell membranes. Proc Natl Acad Sci USA, 84:6457-6461.
93. Song WK, Wang W, Sato H, Bielser DA, Kaufman SJ. 1993. Expression of alpha 7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases. J Cell Sci 106:1139-1152.
94. Sorokin LM, Conzelmann S, Ekblom P, Aumailley M, Battalia C, Timpl R 1992. Monoclonal antibodies against laminin A chain fragment E3 and their effects on cell-and heparin-binding, and on kidney development. Exp Cell Res 201:137-144.
95. Stirling CA. 1975. Abnormalities in Schwann cell sheaths in spinal nerve roots of dystrophic mice. J Anat 119:169-180.
96. Straub V, Rafael JA, Chamberlain JS, Campbell KP. 1997. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139:375-385.
97. Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP. 1994. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem 269:13729-13732.
98. Sunada Y, Bernier SM, Utani A, Yamada Y, Campbell KP. 1995a. Identification of a novel mutant transcript of laminin α2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice. Hum Mol Genet 4:1055-1061.
99. Sunada Y, Edgar TS, Lotz BP, Rust RS, Campbell KP. 1995b. Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 45:2084-2089.
100. Takada K, Nakamura H, Tanaka J. 1984. Cortical dysplasia in congenital muscular dystrophy with central nervous system involvement (Fukuyama type). J Neuropathol Exp Neurol 43:395-407.
101. Taratuto AL, Lubieniecki F, Diaz D, Schultz M, Ruggieri V, Saccoliti M, Dubrovsky A. 1999. Merosin-deficisnt congenital muscular dystrophy associated with abnormal cerebral cortical gyration: an autopsy study. Neuromusc Disord 9:86-94.
102. Tian M, Hagg T, Denisova N, Knusel B, Engvall E, Jucker M. 1997. Laminin α2 chain-like antigens in CNS dendritic spines. Brain Res 764:28-38.
103. Tiger CF, Champliaud MF, Pedrosa-Domellof F, Thornell LE, Ekblom P, Gullberg D. 1997. Presence of laminin alpha5 chain and lack of laminin alpha1 chain during human muscle development and in muscular dystrophies. J Biol Chem 272:28590-28595.
104. Timpl R. 1996. Macromolecular organization of basement membranes. Curr Opin Cell Biol 8:618-624.
105. Tomé FMS, Evangelista T, Leclerc A, Sunada Y, Manole E, Estournet B, Barois A, Campbell KP, Fardeau M. 1994. Congenital muscular dystrophy with merosin deficiency. CR Acad Sci [III] 317:351-357.
106. Trevisan CP, Martinello F, Ferruzza E, Fanin M, Chevallay M, Tome FM. 1996. Brain alterations in the classical form of congenital muscular dystrophy. Clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in the muscle. Child Nerv Syst 12:604-610.
107. Vachon PH, Loechel F, Xu X, Wewer UM, Engvall E. 1996. Merosin and Laminin in Myogenesis; Specific requirement for Merosin in myotube stability and survival. J Cell Biol 134:1483-1497.
108. Vachon PH, Xu H, Liu L, Loechel F, Hayashi Y, Arahata K, Reed JC, Wewer UM, Engvall E. 1997. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest 100:1870-1881.
109. Vainzof M, Marie SK, Reed UC, Schwartzman JS, Pavanello RC, Passos-Bueno MR, Zatz M. 1995. Deficiency of merosin (laminin M or α2) in congenital muscular dystrophy associated with cerebral white matter alterations. Neuropediatrics 26:293-297.
110. Valanne L, Pihko H, Katevuo K, Karttunen P, Somer H, Santavuori P. 1994. MRI of the brain in muscle-eye-brain (MEB) disease. Neuroradiology 36:473-476.
111. van der Knaap MS, Smit LM, Earth PG, Catsman-Berrevoets CE, Brouwer OF, Begeer JH, de Coo IF, Valk J. 1997. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 42:50-59.
112. Vidal F, Baudoin C, Miquel C, Galliano MF, Christiano AM, Uitto J, Ortonne JP, Meneguzzi G. 1995. Cloning of the laminin alpha 3 chain gene (LAMA3), identification of a homozygous deletion in a patient with Herlitz junctional epidermolysis bullosa. Genomics 30:273-280.
113. Villanova M, Malandrini A, Sabatelli P, Sewry CA, Toti P, Torelli S, Six J, Scarfo G, Palma L, Muntoni F, Squarzoni S, Tosi P, Maraldi NM, Guazzi GC. 1997. Localization of laminin alpha 2 chain in normal human central nervous system: an immunofluorescence and ultrastructual study. Acta Neuropathol 94:567-571.
114. Vilquin J-T, Besse S, Vignier N, Poirier C, Engvall E, Guicheney P, Fiszman M, Schwartz K. 1999. Advances in animal models and gene complementation strategies for congenital muscular dystrophy. 3rd Japanese-French Workshop on Muscular dystrophies. May 29-30. Tokyo, Japan.
115. Vuolteenaho R, Nissinen M, Sainio K, Byers M, Eddy R, Hirvonen H, Shows TB, Sariola H, Engvall E, Tryggvason K. 1994. Human laminin M chain (merosin): Complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 124:381-394.
116. Weinberg HJ, Spencer PS, Raine CS. 1975. Aberrant PNS development in dystrophic mice. Brain Res 88:532-537.
117. Worton R. 1995. Muscular dystrophies: diseases of the dystrophin-glycoprotein complex. Science 270:755-756.
118. Xu H, Wu X-R, Wewer UM, Engvall E. 1994a. Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2). gene. Nat Genet 8:297-301.
119. Xu H, Christmas P, Wu X-R, Wewer UM, Engvall E. 1994b. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA 91:5572-5576.
120. Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K. 1994. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 352:49-53.
121. Yamada H, Chiba A, Endo T, Kobata A, Anderson LVB, Hori H, Fukuta-Ohi H, Kanazawa I, Campbell KP, Shimizu T, Matsumura K. 1996. Characterization of dystroglycan-laminin interaction in peripheral nerve. J Neurochem 66:1518-1524.
122. Yao CC, Ziober BL, Sutherland AE, Mendrick DL, Kramer RH. 1996. Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. J Cell Sci 109:3139-3150.
123. Yurchenco PD, O'Rear JJ. 1994. Basal lamina assembly. Curr Opin Cell Biol 6:674-681.
124. Zhang X, Vuolteenaho R, Tryggvason K. 1996. Structure of the human laminin α2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. J Biol Chem 271:27664-27669.